• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Dihydrocytochalasin B

Dihydrocytochalasin B

Product ID D3429
Cas No. 39156-67-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $300.60 In stock
5 mg $1,239.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Dihydrocytochalasin B is a mycotoxin derivative that inhibits actin polymerization, preventing mitosis. Dihydrocytochalasin B exhibits anti-parasitic activity, inhibiting the growth of Entamoeba invadens. Additionally, dihydrocytochalasin B exhibits neuromodulatory activity, enhancing the conversion of Kv1.1 K+ channels to A-type K+ channels.

Product Info

Cas No.

39156-67-7

Purity

≥98%

Formula

C29H39NO5

Formula Wt.

481.62

IUPAC Name

(1S,6R,10R,12E,14S,15S,17S,18S,19S)-19-benzyl-6,15-dihydroxy-10,17-dimethyl-16-methylidene-2-oxa-20-azatricyclo[12.7.0.01,18]henicos-12-ene-3,21-dione

Melting Point

203-205°C

Solubility

Acetone, DMSO, 100% Ethanol, Methanol

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

D3429 MSDS PDF

Info Sheet

D3429 Info Sheet PDF

References

Makioka A, Kumagai M, Kobayashi S, et al. Different effects of cytochalasins on the growth and differentiation of Entamoeba invadens. Parasitol Res. 2004 May;93(1):68-71. PMID: 15103555.

Reshetnikova G, Barkan R, Popov B, et al. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Exp Cell Res. 2000 Aug 25;259(1):35-53. PMID: 10942577.

Jing J, Chikvashvili D, Singer-Lahat D, et al. Fast inactivation of a brain K+ channel composed of Kv1.1 and Kvbeta1.1 subunits modulated by G protein beta gamma subunits. EMBO J. 1999 Mar 1;18(5):1245-56. PMID: 10064591.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P0244

    Palbociclib Hydrochloride

    CDK4/6 inhibitor.

    ≥99%
  • H9611

    Hydrocortisone

    Endogenous steroid hormone involved in stress s...

    ≥98%
  • R0351

    Ramoplanin

    Peptide; peptidoglycan inhibitor.

    ≥90%
  • D022705

    Darunavir

    HIV and AIDS

    ≥99%
  • S9753

    Synephrine

    Endogenous alkaloid also found in citrus fruits...

    ≥98%
  • P0254

    Panaxatriol

    Triterpene sapogenin found in species of Panax;...

    ≥98%
  • V5870

    Vortioxetine

    5-HT1A agonist, 5-HT1B partial agonist, 5-HT3A/...

    ≥99%
  • C1629

    Cefoperazone Acid

    β-lactam cephalosporin; penicillin binding pro...

    ≥98%
  • T0008

    Tacrolimus

    Calcineurin inhibitor.

    ≥98%
  • B5875

    Bosutinib, structural isomer

    Bosutinib isomer; Src and Abl inhibitor.

    ≥98%
  • W9600

    WZ-4002

    EGFR (T790M) inhibitor.

    ≥98%
  • C0270

    Carbamazepine

    GABA potentiator, voltage-gated Na+ and ATP-sen...

    ≥98%
  • N3323

    Nifuratel

    Nitrofuran derivative.

    ≥99%
  • P7000

    PR-619

    Deubiquitinating enzyme inhibitor.

    ≥98%
  • F465817

    Flunisolide

    Corticosteroid

    ≥90%
  • A2401

    AG-18

    EGFR and PDGFR inhibitor

    ≥98%
  • A488246

    AMG-232

    MDM2-p53 inhibitor

    ≥99%
  • P6954

    Pioglitazone Hydrochloride

    Thiazolidinedione; PPARα/γ agonist, mitoNEET ...

    ≥98%
  • C224760

    CFT-7455

    Degrader of IKZF1/3

    ≥98%
  • T3132

    Thiazovivin

    ROCK inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only